Tag: Skin Disorders: Itchiness
Nemolizumab Improves Symptoms in Prurigo Nodularis
Treatment efficacy seen in primary end points of itch response and Investigator's Global Assessment response
Nemolizumab Beats Placebo for Reduction of Pruritus in Eczema
VAS score reduction greater at week 16 for addition of nemolizumab versus placebo to topical agents
ASN: Difelikefalin Improves Itch in CKD-Linked Pruritus
Findings seen among patients on hemodialysis with moderate-to-severe pruritus
Pruritus Prevalent and Disruptive in Nondialysis Chronic Kidney Disease
Patients with pruritus have higher prevalence of patient-reported depression, restless sleep
Review Highlights Lack of Tx Options for Prurigo Nodularis
Researchers call for more randomized controlled trials to investigate systemic treatments
Serlopitant Found to Be Safe, Effective for Chronic Pruritus
Findings show a dose-dependent response in decrease in itchiness
New Framework Guides Tx Decisions for Atopic Dermatitis
Recommendations made as part of consensus statement by International Eczema Council
High Prevalence of Alcohol Use Disorders in Eczema
Significantly increased odds ratios for alcohol use disorder in eczema after adjustment for age, gender
Rapid, Clinically Meaningful Psoriasis Relief With Ixekizumab
Three clinical trials show significant improvements for ixekizumab versus etanercept, placebo
Pain and Itch Highly Prevalent Months After Herpes Zoster
Pain linked to increased costs and has large impact on quality of life; itch has limited impact on QoL
